You may also be interested in...
Accessing the inaccessible: research bridging academia and industry – an interview with Tatiana Rogova
Expert interviews, Drug discovery approaches, Drug regulation and industry, Preclinical studies and Phase I, Technologies and methodologies, Neurological & Psychiatric , Respiratory , Cardiovascular , Digestive , Infectious , Cancer , Early Career Room
Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer
Free-energy analysis in drug discovery: an interview with Stefano Leoni
The importance of versatility in controlled drug delivery: an interview with Jos Paulusse